Literature DB >> 20432301

Dynamic susceptibility contrast MRI with localized arterial input functions.

John J Lee1, G Larry Bretthorst, Colin P Derdeyn, William J Powers, Tom O Videen, Abraham Z Snyder, Joanne Markham, Joshua S Shimony.   

Abstract

Compared to gold-standard measurements of cerebral perfusion with positron emission tomography using H(2)[(15)O] tracers, measurements with dynamic susceptibility contrast MR are more accessible, less expensive, and less invasive. However, existing methods for analyzing and interpreting data from dynamic susceptibility contrast MR have characteristic disadvantages that include sensitivity to incorrectly modeled delay and dispersion in a single, global arterial input function. We describe a model of tissue microcirculation derived from tracer kinetics that estimates for each voxel a unique, localized arterial input function. Parameters of the model were estimated using Bayesian probability theory and Markov-chain Monte Carlo, circumventing difficulties arising from numerical deconvolution. Applying the new method to imaging studies from a cohort of 14 patients with chronic, atherosclerotic, occlusive disease showed strong correlations between perfusion measured by dynamic susceptibility contrast MR with localized arterial input function and perfusion measured by quantitative positron emission tomography with H(2)[(15)O]. Regression to positron emission tomography measurements enabled conversion of dynamic susceptibility contrast MR to a physiologic scale. Regression analysis for localized arterial input function gave estimates of a scaling factor for quantitation that described perfusion accurately in patients with substantial variability in hemodynamic impairment. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432301      PMCID: PMC3014609          DOI: 10.1002/mrm.22338

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  35 in total

1.  Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI.

Authors:  E P Vonken; F J Beekman; C J Bakker; M A Viergever
Journal:  Magn Reson Med       Date:  1999-02       Impact factor: 4.668

2.  On the theory of the indicator-dilution method for measurement of blood flow and volume.

Authors:  P MEIER; K L ZIERLER
Journal:  J Appl Physiol       Date:  1954-06       Impact factor: 3.531

3.  Automatic selection of arterial input function using cluster analysis.

Authors:  Kim Mouridsen; Søren Christensen; Louise Gyldensted; Leif Ostergaard
Journal:  Magn Reson Med       Date:  2006-03       Impact factor: 4.668

4.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

Authors:  L Ostergaard; A G Sorensen; K K Kwong; R M Weisskoff; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

5.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

6.  Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects.

Authors:  A Villringer; B R Rosen; J W Belliveau; J L Ackerman; R B Lauffer; R B Buxton; Y S Chao; V J Wedeen; T J Brady
Journal:  Magn Reson Med       Date:  1988-02       Impact factor: 4.668

7.  Brain blood volume, flow, and oxygen utilization measured with 15O radiotracers and positron emission tomography: revised metabolic computations.

Authors:  T O Videen; J S Perlmutter; P Herscovitch; M E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  1987-08       Impact factor: 6.200

8.  Positron emission tomography to assess cerebral perfusion.

Authors:  W J Powers; M E Raichle; R L Grubb
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

9.  Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values.

Authors:  L Ostergaard; D F Smith; P Vestergaard-Poulsen; S B Hansen; A D Gee; A Gjedde; C Gyldensted
Journal:  J Cereb Blood Flow Metab       Date:  1998-04       Impact factor: 6.200

10.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

Authors:  R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers
Journal:  JAMA       Date:  1998 Sep 23-30       Impact factor: 56.272

View more
  10 in total

1.  Correction for arterial-tissue delay and dispersion in absolute quantitative cerebral perfusion DSC MR imaging.

Authors:  Jessy J Mouannes-Srour; Wanyong Shin; Sameer A Ansari; Michael C Hurley; Parmede Vakil; Bernard R Bendok; John L Lee; Colin P Derdeyn; Timothy J Carroll
Journal:  Magn Reson Med       Date:  2011-12-12       Impact factor: 4.668

2.  Heterogeneous Optimization Framework: Reproducible Preprocessing of Multi-Spectral Clinical MRI for Neuro-Oncology Imaging Research.

Authors:  Mikhail Milchenko; Abraham Z Snyder; Pamela LaMontagne; Joshua S Shimony; Tammie L Benzinger; Sarah Jost Fouke; Daniel S Marcus
Journal:  Neuroinformatics       Date:  2016-07

3.  An extended vascular model for less biased estimation of permeability parameters in DCE-T1 images.

Authors:  Siamak P Nejad-Davarani; Hassan Bagher-Ebadian; James R Ewing; Douglas C Noll; Tom Mikkelsen; Michael Chopp; Quan Jiang
Journal:  NMR Biomed       Date:  2017-02-17       Impact factor: 4.044

4.  Modeling Dynamic Contrast-Enhanced MRI Data with a Constrained Local AIF.

Authors:  Chong Duan; Jesper F Kallehauge; Carlos J Pérez-Torres; G Larry Bretthorst; Scott C Beeman; Kari Tanderup; Joseph J H Ackerman; Joel R Garbow
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

Review 5.  MR perfusion imaging in acute ischemic stroke.

Authors:  William A Copen; Pamela W Schaefer; Ona Wu
Journal:  Neuroimaging Clin N Am       Date:  2011-05       Impact factor: 2.264

6.  Comparison of perfusion- and diffusion-weighted imaging parameters in brain tumor studies processed using different software platforms.

Authors:  Mikhail V Milchenko; Dhanashree Rajderkar; Pamela LaMontagne; Parinaz Massoumzadeh; Ronald Bogdasarian; Gordon Schweitzer; Tammie Benzinger; Dan Marcus; Joshua S Shimony; Sarah Jost Fouke
Journal:  Acad Radiol       Date:  2014-08-01       Impact factor: 3.173

7.  The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers.

Authors:  Sarah Jost Fouke; Tammie L Benzinger; Mikhail Milchenko; Pamela LaMontagne; Joshua S Shimony; Michael R Chicoine; Keith M Rich; Albert H Kim; Eric C Leuthardt; Bart Keogh; Daniel S Marcus
Journal:  Neurosurgery       Date:  2014-01       Impact factor: 4.654

8.  RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm.

Authors:  Paul Pang; Xiaohua Jin; Brandon M Proctor; Michelle Farley; Nilay Roy; Matthew S Chin; Ulrich H von Andrian; Elisabeth Vollmann; Mario Perro; Ryan J Hoffman; Joseph Chung; Nikita Chauhan; Murti Mistri; Anthony J Muslin; Joseph V Bonventre; Andrew M Siedlecki
Journal:  Kidney Int       Date:  2014-12-03       Impact factor: 10.612

9.  Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation.

Authors:  Qing Wang; Gloria J Guzmán Pérez-Carrillo; Maria Rosana Ponisio; Pamela LaMontagne; Sonika Dahiya; Daniel S Marcus; Mikhail Milchenko; Joshua Shimony; Jingxia Liu; Gengsheng Chen; Amber Salter; Parinaz Massoumzadeh; Michelle M Miller-Thomas; Keith M Rich; Jonathan McConathy; Tammie L S Benzinger; Yong Wang
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

10.  Dissociation Between Hormonal Counterregulatory Responses and Cerebral Glucose Metabolism During Hypoglycemia.

Authors:  John J Lee; Nadia Khoury; Angela M Shackleford; Suzanne Nelson; Hector Herrera; Jo Ann Antenor-Dorsey; Katherine Semenkovich; Joshua S Shimony; William J Powers; Philip E Cryer; Ana María Arbeláez
Journal:  Diabetes       Date:  2017-10-02       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.